الملخص
Infection with the hepatitis C virus (HCV) is a worldwide problem. Patients with chronic HCV infection who are non-responders to standard therapy represent a growing population within the HCV epidemic.Novel, more efficient and tolerable therapies are urgently needed. This review discusses the recent results showing that targeting miR-122, a micro-ribonucleic acid (MicroRNA) that enhances HCV replication, is a new anti-HCV therapy with a high barrier to resistance.
بيانات النشر
- المعرّف الرقمي
- 10.18295/2075-0528.1211
- المجلة
- مجلة جامعة السلطان قابوس الطبية, 10(3), 312-317
- الناشر
- جامعة السلطان قابوس
- وصول مفتوح
- وصول مفتوح ذهبي
- الترخيص
- CC BY-ND 4.0
اقتبس هذه المقالة
APA 7
Said, E. A. (2025). The Need for New Anti-Hepatitis C Virus Therapeutic Strategies: Targeting the cellular micro-ribonucleic acids? Sultan Qaboos University Medical Journal, 10(3), 312-317. https://doi.org/10.18295/2075-0528.1211
MLA 9
Said, Elias A. "The Need for New Anti-Hepatitis C Virus Therapeutic Strategies: Targeting the cellular micro-ribonucleic acids?" Sultan Qaboos University Medical Journal, vol. 10, no. 3, 2025, pp. 312-317. https://doi.org/10.18295/2075-0528.1211.
شيكاغو (المؤلف–التاريخ)
Said, Elias A. 2025. "The Need for New Anti-Hepatitis C Virus Therapeutic Strategies: Targeting the cellular micro-ribonucleic acids?" Sultan Qaboos University Medical Journal 10 (3): 312-317. https://doi.org/10.18295/2075-0528.1211.
هارفارد
Said, E. A. (2025) 'The Need for New Anti-Hepatitis C Virus Therapeutic Strategies: Targeting the cellular micro-ribonucleic acids?', Sultan Qaboos University Medical Journal, 10(3), pp. 312-317. doi:10.18295/2075-0528.1211.
فانكوفر
Said EA. The Need for New Anti-Hepatitis C Virus Therapeutic Strategies: Targeting the cellular micro-ribonucleic acids? Sultan Qaboos University Medical Journal. 2025;10(3):312-317. doi:10.18295/2075-0528.1211
IEEE
E. A. Said, "The Need for New Anti-Hepatitis C Virus Therapeutic Strategies: Targeting the cellular micro-ribonucleic acids?," Sultan Qaboos University Medical Journal, vol. 10, no. 3, pp. 312-317, 2025, doi: 10.18295/2075-0528.1211.